Methods and devices for nebulizing fluids

Information

  • Patent Grant
  • 6543443
  • Patent Number
    6,543,443
  • Date Filed
    Wednesday, July 12, 2000
    24 years ago
  • Date Issued
    Tuesday, April 8, 2003
    21 years ago
Abstract
A nebulizing device having two or more nebulizing elements. The nebulizing device may be used to deliver two or more fluids to the patient or may be used for enhanced fluid flow of a single fluid. The nebulizing elements are preferably vibrating elements with holes therein through which the fluid is expelled when the vibrating elements are vibrated.
Description




BACKGROUND OF THE INVENTION




The present invention is directed to methods and devices for nebulizing fluids. In a specific application of the present invention, the device is used to nebulize fluids for delivery to the lungs. Although the present invention is particularly useful for nebulizing fluids for inhalation, it is understood that the present invention may be used for nebulizing fluids in other fields and for other purposes.




SUMMARY OF THE INVENTION




In a first aspect of the present invention, a nebulizing device is provided which has at least two nebulizing elements. In a preferred embodiment, the nebulizing element has a vibrating element with a plurality of apertures. The vibrating element is preferably a relatively stiff element, such as a rigid dome-shaped element, but may be any other suitable structure. The vibrating elements are vibrated to expel fluid through the apertures.




The device may be operated to provide independent delivery of two different fluids. In a specific application of the present invention for nebulizing liquids for inhalation, the first fluid may contain an immune modulator or a mucolytic, such as alpha dornase, and the second fluid could contain an antibiotic, such as an aminoglycocide like tobramicin, or quinolone, pentamidine, or an antifungal such as amphotericin B. Another application for the device is for the first fluid to contain a short acting beta agonist and the second fluid to contain a corticosteroid. The beta agonist provides symptomatic relief and the corticosteroid treats the underlying immune reaction. The beta agonist may be any suitable beta agonist such as albuterol. These drugs complement one another in the treatment of asthma. Other combinations of drugs may be delivered with the device which relate to the same ailment or to different ailments.




The first and second fluids may also be delivered in the same breath. In one aspect, the first fluid may be delivered earlier than the second fluid. For example, the first fluid could contain a bronchodilator which opens the lungs for delivery of the second fluid. Alternatively, the second fluid could be a bronchorestrictor delivered after the first fluid to help retain the first fluid in the lungs. Of course, any combinations of liquids may be delivered as the first and second fluids and the examples given are merely illustrative.




Although the device may be operated to deliver two or more fluids, the device may be used to deliver a single fluid. When delivering only one fluid, the combination of nebulizers provides enhanced flow. For example, the nebulizing elements may together be used to deliver 40-300 microliters, more preferably 100-250 microliters, in one breath. Stated another way, the nebulizing elements are used to deliver at least 100 microliters and more preferably at least 200 microliters of fluid in one breath by the user. Stated still another way, the device delivers the preferred amounts in no more than four seconds of operating time. The first and second nebulizers also provide the ability to provide relatively large increases and decreases in fluid flow rate by simply activating or de-activating one or more of the nebulizers. Of course, the flow rate of each of the nebulizers may be adjusted by changing the power or frequency of operation.




In another aspect of the present invention, the nebulizer may also instruct or permit the user to inhale a set number of doses over a period of time. For example, the device may permit and/or instruct the user to inhale six doses of the first fluid, such as a beta agonist, per day and only two doses of the second fluid, such as a corticosteroid. The control system may also permit a set number of doses of one of the fluids in relation to the amount of the other fluid delivered. In this manner, the relative amounts of the two fluids can be regulated.











These and other advantages and features will become apparent with the following description of the preferred embodiments, drawings and claims.




BRIEF DESCRIPTION OF THE DRAWINGS





FIG. 1

is an isometric view of a device in accordance with the present invention.





FIG. 2

shows the device with a door and mouthpiece removed to expose internal components of the device.





FIG. 3

is a side view of another fluid delivery system for the device.





FIG. 4

is an exploded side of a vibrating element and a fluid receptacle.





FIG. 5

is a side view of the vibrating element and fluid receptacle.





FIG. 6

is an end view of the assembly of FIG.


5


.





FIG. 7

is a cross-sectional view of an end of the assembly of

FIG. 5

around line A—A.





FIG. 8

is a partial cross-sectional view of the fluid delivery system for the device of

FIGS. 3-7

.





FIG. 9

shows a single fluid container.











DESCRIPTION OF THE SPECIFIC EMBODIMENTS




Referring to

FIGS. 1 and 2

, a nebulizing device


2


is shown. The nebulizing device


2


includes a housing


4


having a mouthpiece


6


and a door


8


. The door


8


and mouthpiece


6


are removed in FIG.


2


. The door


8


is coupled to the housing


4


with hinges


10


to open and close the door


8


. As explained above, the nebulizing device


2


of the present invention may be used for a number of different applications and a preferred application is as a hand-held, portable device for delivery of at least one fluid to the lungs.




In one aspect of the invention, the nebulizing device


2


has at least two nebulizing elements


12


. As will be described in greater detail below, the nebulizing elements


12


provide the ability to control the delivery of two different drugs to the patient. This can be important when two or more drugs are delivered to treat the same ailment. The drugs may be delivered at the same time or at different times in a controlled manner. The combination of nebulizing elements


12


also provides high flow rates when only a single drug is delivered with the nebulizing elements


12


.




The fluid is contained in first and second fluid cartridges


14


,


16


. The fluid may be contained in any suitable container and a preferred container is an ampoule


18


. The fluid may be delivered from the cartridges


14


,


16


to the nebulizing elements


12


in any manner. A capillary feed system


20


and a system for delivering single doses are described below. The device


2


is designed so that the fluid cartridges


14


,


16


can be replaced a number of times for subsequent use. It is understood that the fluid may be delivered in any other manner such as delivering a number of discrete volumes from a capsule using a piston.




The device


2


may be similar in construction and design to the devices described in U.S. Pat. No. 5,758,637 and U.S. Pat. No. 6,014,970, which are hereby incorporated by reference, although any other suitable structure may be used. The ampoule


18


preferably has a flange


22


which registers with slots


24


in the device


2


. Fluid from the cartridge


14


is delivered to the nebulizing elements


12


with the capillary feed system


20


such as the capillary feed systems described in U.S. Pat. No. 5,938,117 and U.S. Pat. No. 5,758,637 which are incorporated here by reference.




Referring to

FIGS. 3-8

, another fluid delivery system is shown which is an alternative to the capillary system


20


described in connection with

FIGS. 1 and 2

. The system is designed to receive single dose ampoules


18


which are replaced after each use. The ampoule


18


fits within an adapter


26


. The adapter


26


and ampoule


18


are preferably packaged together as a unit but may also be separate. The adapter


26


has a lip


28


which engages a fluid receptacle


30


. The fluid receptacle


30


is large enough to accommodate the entire volume of the ampoule


18


. In the preferred embodiment, the fluid receptacle


30


holds about 15 microliters to 2 milliliters and preferably about 500 microliters.




The fluid receptacle


30


is generally funnel-shaped and extends upward to an opening


32


which mates with the adapter


26


. The fluid receptacle


30


has a second opening


34


which fits around a vibrating element


36


. The vibrating element


36


has openings


37


therein and a backside


39


exposed to fluid in the fluid receptacle


30


. Lateral tabs


38


extend from the receptacle


30


and engage an opening


40


in a holder


42


. The vibrating element


36


is mounted around an opening


46


in a cup-shaped element


44


and the cup-shaped element is held within the holder


42


. The vibrating element


36


has the apertures


37


through which fluid is expelled when the element


36


is vibrated. The receptacle


30


is preferably adhered to the element


36


with an adhesive such as silicone. The vibrating element


36


is vibrated with a ring-shaped piezoelectric member


48


mounted to the holder


42


. Wires


50


connect the piezoelectric member


48


to a control system


51


. The nebulizing element


12


may be any suitable device or structure and is preferably dome-shaped and manufactured in the manner described in U.S. Pat. No. 6,014,970 incorporated above.




The ampoule


18


is pierced by a first spike


52


which delivers fluid from the cartridge


14


,


16


to the receptacle


30


. The first spike


52


is mounted to the adapter


26


and is replaced with the adapter after each use. A second spike


54


introduces air into the cartridge


14


,


16


as fluid is drained into the receptacle


30


for smooth delivery of the fluid. The first and second spikes


52


,


54


automatically pierce the cartridge


14


,


16


when the door


8


is closed. The second spike


54


is mounted to a top


56


which is driven into the receptacle


30


when the door


8


is closed. Although the fluid is delivered to the nebulizing element


12


in finite amounts or with capillary feed, the fluid may also be delivered to the nebulizing elements


12


in any other manner. For example, the fluid cartridge


14


,


16


may contain a number of doses with the dose size being selected using conventional methods of delivering small amounts of fluid.




Referring to

FIG. 9

, the device


2


may also have a single fluid cartridge


58


. The fluid cartridge


58


may contain separate compartments for two different fluids. The fluid cartridge


58


may also simply contain a single fluid which is delivered to both nebulizing elements


12


. When delivering only one fluid, the combination of nebulizers


12


provides the ability to produce large flow rates. For example, the nebulizing elements


12


may together be used to deliver 40-300 microliters, more preferably 100-250 microliters, in one breath. Stated another way, the nebulizing elements


12


are used to deliver at least 100 microliters and more preferably at least 200 microliters of fluid in one breath by the user. The nebulizing elements


12


also occupy a relatively small area so that the device is compact. The first and second nebulizers


12


also provide the ability to provide relatively large increases and decreases in fluid flow rate by simply activating or de-activating one or more of the nebulizers


12


. Of course, the flow rate through each of the nebulizers may be adjusted by changing the power and/or frequency of operation.




The control system


51


controls the nebulizing elements and/or instructs the user on use of the device


2


. The device has one or more indicators which may be audible or visual such as a clock, timer, or display which tells the user when and/or how to use the device. In a preferred embodiment, the indicator indicates one of more of the following: when the user should take a dose of one or more of the fluids, when the fluid is ready for inhalation, when the nebulizing element has been activated, and/or upon completion of a breath hold time. In one mode of operation, the indicator is simply a light. The user loads one or more cartridges


14


,


16


and closes the door to deliver the fluid to the receptacle


30


. When the dose is ready, the green light may flash which indicates that the user may activate the device


2


. The device may be actuated with a button (not shown) or with a flow activated sensor. The light may remain on when the nebulizing element


12


has been activated and remains illuminated until a breath hold period is completed. The breath hold period may be set to be any value such as five seconds after completing delivery of the fluid. The visual indicators described herein are merely an example of a system for controlling and instructing the user in use of the device and many other variations for the control system may be used without departing from various aspects of the invention.




The device


2


may be operated in various other modes now described. Of course, the device


2


may operate in still different modes without departing from various aspects of the invention. In a first mode of operation, the first and second fluids may be delivered in the same breath or may be delivered independently. In a specific application of the present invention, the first fluid may contain a mucolytic, such as alpha dornase, and the second fluid may contain an antibiotic, such as an aminoglycocide like tobramicin, or quinolone, pentamidine, or an antifungal such as amphotericin B. The control system


51


may also permit and prevent a set number of doses over a period of time. For example, the nebulizing device


2


may permit the user to have a set number of doses of the first fluid, such as six doses of the beta agonist per day, while permitting another set number of doses of the second fluid, such as two doses of the corticosteroid per day. In this manner, a single device


2


may be used to control the relative delivery of two different fluids.




The control system


51


may also operate to deliver the first and second fluids in the same breath. For example, the first fluid may be delivered before completing delivery of the second fluid. When operating in this mode, the first fluid may contain any suitable fluid such as a bronchodilator which opens the lungs in preparation for receiving the second fluid. The second fluid may be also delivered after the first or “main” fluid. The second fluid may be any suitable fluid such as a bronchorestrictor. Of course, the first and second fluids may be delivered simultaneously for a period of time without departing from the scope of the invention.




Finally, the control system


51


may operate to deliver different amounts of the first and second fluids in any of the modes described above. For example, the first fluid may be a short acting insulin and the second fluid may be a long acting insulin. The control system


51


may deliver different amounts of the two fluids such as twice as much short acting insulin as long acting insulin.




The invention has been described by way of the preferred embodiments, the invention should not be limited to the specific embodiments since various modifications and changes can be incorporated without departing from the scope of the invention. For example, the nebulizing elements may be relatively flat elements, the fluid container may be a titratable capsule, and the device may have three or more nebulizers. Finally, the invention has been described with respect to various features and aspects of the invention and it is understood that these features and aspects are independent of one another and none of the features or aspects should be considered essential or indispensable relative to the other features and aspects. For example, aspects of the fluid delivery system may be practiced with a device having only one nebulizing element and aspects of the multi-nebulizer device may be practiced with an entirely different fluid delivery system.



Claims
  • 1. A method of nebulizing a substance, comprising the steps of:providing a device having a housing, a first nebulizer, and a second nebulizer, the first and second nebulizers being mounted within the housing; delivering fluid to the first and second nebulizers, the fluid delivering step being carried out with a fluid cartridge mounted to the housing, the fluid being delivered to both the first and second nebulizers from the cartridge, the fluid delivering step being carried out with the fluid cartridge having a first fluid container containing a first fluid and a second fluid container containing a second fluid, the first fluid container supplying the first fluid to the first nebulizer and the second fluid container supplying the second fluid to the second nebulizer; activating the first and second nebulizers thereby nebulizing the fluid.
  • 2. The method of claim 1, wherein:the providing step is carried out with the first nebulizer having a first vibrating element having a first plurality of apertures and the second nebulizer has a second vibrating element having a second plurality of apertures.
  • 3. The method of claim 1, wherein:the fluid delivering step is carried out with the first fluid being a fluid selected from the group consisting of beta-agonist, mucolytic, and an immune modulator and the second fluid is a fluid selected from the group consisting of an antibiotic, an antifungal, and a corticosteroid.
  • 4. The method of claim 1, wherein:the activating step is carried out with the first and second nebulizers being activated for different lengths of time.
  • 5. The method of claim 1, wherein:the activating step is carried out with the first and second nebulizers being activated at the same time.
  • 6. The method of claim 1, wherein:the delivering step is carried out with discrete volumes of fluid being delivered to the first and second nebulizers.
  • 7. The method of claim 1, wherein:the providing step is carried out with the housing having a mouthpiece; and the method further comprising the step of inhaling through the mouthpiece to deliver the nebulized fluid to the lungs.
  • 8. The method of claim 1, wherein:the delivering step is carried out by delivering 40-300 microliters of fluid in one breath.
  • 9. The method of claim 8, wherein:the delivering step is carried out by delivering at least 100 microliters in one breath.
  • 10. The method of claim 8, wherein:the delivering step is carried out by delivering at least 200 microliters of fluid in one breath.
  • 11. The method of claim 10, wherein:the delivering step is carried out by delivering the amount in less than four seconds.
  • 12. A method of nebulizing a substance, comprising the steps of:providing a device having a housing, a first nebulizer, and a second nebulizer, the first and second nebulizers being mounted within the housing; delivering fluid to the first and second nebulizers, the fluid delivering step being carried out with a fluid cartridge mounted to the housing, the fluid being delivered to both the first and second nebulizers from the cartridge; activating the first and second nebulizers thereby nebulizing the fluid, the activating step being carried out with the first and second nebulizers being activated at the same time.
  • 13. The method of claim 12, wherein:the providing step is carried out with the first nebulizer having a first vibrating element having a first plurality of apertures and the second nebulizer has a second vibrating element having a.second plurality of apertures.
  • 14. The method of claim 12, wherein:the fluid delivering step is carried out with the fluid cartridge having a first fluid container containing a first fluid and a second fluid container containing a second fluid, the first fluid container supplying the first fluid to the first nebulizer and the second fluid container supplying the second fluid to the second nebulizer.
  • 15. The method of claim 14, wherein:the fluid delivering step is carried out with the first fluid being a fluid selected from the group consisting of beta-agonist, mucolytic, and an immune modulator and the second fluid is a fluid selected from the group consisting of an antibiotic, an antifungal, and a corticosteroid.
  • 16. The method of claim 12, wherein:the activating step is carried out with the first and second nebulizers being activated for different lengths of time.
  • 17. The method of claim 12, wherein:the delivering step is carried out with discrete volumes of fluid being delivered to the first and second nebulizers.
  • 18. The method of claim 12, wherein:the providing step is carried out with the housing having a mouthpiece; and the method further comprising the step of inhaling through the mouthpiece to deliver the nebulized fluid to the lungs.
  • 19. The method of claim 12, wherein:the delivering step is carried out by delivering 40-300 microliters of fluid in one breath.
  • 20. The method of claim 19, wherein:the delivering step is carried out by delivering at least 100 microliters in one breath.
  • 21. The method of claim 19, wherein:the delivering step is carried out by delivering at least 200 microliters of fluid in one breath.
  • 22. The method of claim 21, wherein:the delivering step is carried out by delivering the amount in less than four seconds.
US Referenced Citations (153)
Number Name Date Kind
2101304 Wright Dec 1937 A
2158615 Wright May 1939 A
2187528 Wing Jan 1940 A
2223541 Baker Dec 1940 A
2266706 Fox et al. Dec 1941 A
2283333 Martin May 1942 A
2292381 Klagges Aug 1942 A
2360297 Wing Oct 1944 A
2375770 Dahlberg May 1945 A
2404063 Healy Jul 1946 A
2430023 Longmaid Nov 1947 A
2474996 Wallis Jul 1949 A
2512004 Wing Jun 1950 A
2521657 Severy Sep 1950 A
2681041 Zodtner et al. Jun 1954 A
2779623 Eisenkraft Mar 1957 A
2935970 Morse et al. May 1960 A
3411854 Rosler et al. Nov 1968 A
3558052 Dunn Jan 1971 A
3738574 Guntersdorfer et al. Jun 1973 A
3790079 Berglund et al. Feb 1974 A
3804329 Martner Apr 1974 A
3812854 Michaels et al. May 1974 A
3950760 Ilse-dore Stromberger et al. Apr 1976 A
3958249 DeMaine et al. May 1976 A
3983740 Danel Oct 1976 A
4005435 Lundquist et al. Jan 1977 A
4083368 Freezer Apr 1978 A
4119096 Drews Oct 1978 A
4159803 Cameto et al. Jul 1979 A
4226236 Genese Oct 1980 A
4240081 Devitt Dec 1980 A
4261512 Zierenberg Apr 1981 A
4268460 Boiarski May 1981 A
4294407 Reichl et al. Oct 1981 A
4300546 Kruber Nov 1981 A
4301093 Eck Nov 1981 A
4334531 Reichl et al. Jun 1982 A
4336544 Donald et al. Jun 1982 A
4338576 Takahashi et al. Jul 1982 A
4368476 Uehara et al. Jan 1983 A
4389071 Johnson, Jr. et al. Jun 1983 A
4408719 Last Oct 1983 A
4431136 Janner et al. Feb 1984 A
4454877 Miller et al. Jun 1984 A
4465234 Maehara et al. Aug 1984 A
4474251 Johnson, Jr. Oct 1984 A
4474326 Takahashi Oct 1984 A
4475113 Lee et al. Oct 1984 A
4479609 Maeda et al. Oct 1984 A
4530464 Yamamoto et al. Jul 1985 A
4533082 Maehara et al. Aug 1985 A
4539575 Nilsson Sep 1985 A
4544933 Heinzl Oct 1985 A
4546361 Brescia et al. Oct 1985 A
4550325 Viola Oct 1985 A
4591883 Isayama May 1986 A
4593291 Howkins Jun 1986 A
4605167 Maehara Aug 1986 A
4620201 Heinzl et al. Oct 1986 A
4628890 Freeman Dec 1986 A
4632311 Nakane et al. Dec 1986 A
4659014 Soth et al. Apr 1987 A
4681264 Johnson, Jr. Jul 1987 A
4702418 Carter et al. Oct 1987 A
4722906 Guire Feb 1988 A
4753479 Murphy Jun 1988 A
4790479 Matsumoto et al. Dec 1988 A
4793339 Matsumoto et al. Dec 1988 A
4796807 Bendig et al. Jan 1989 A
4799622 Ishikawa et al. Jan 1989 A
4826759 Guire May 1989 A
4828886 Hieber May 1989 A
4850534 Takahashi et al. Jul 1989 A
4865006 Nogi et al. Sep 1989 A
4877989 Drews et al. Oct 1989 A
4888516 Daeges et al. Dec 1989 A
4968299 Ahlstrand et al. Nov 1990 A
4973493 Guire Nov 1990 A
4976259 Higson et al. Dec 1990 A
4979959 Guire Dec 1990 A
4994043 Ysebaert Feb 1991 A
5002048 Makiej, Jr. Mar 1991 A
5002582 Guire et al. Mar 1991 A
5007419 Weinstein et al. Apr 1991 A
5021701 Takahashi et al. Jun 1991 A
5063396 Shiokawa et al. Nov 1991 A
5063922 Hakkinen Nov 1991 A
5073484 Swanson et al. Dec 1991 A
5076266 Babaev Dec 1991 A
5080649 Vetter Jan 1992 A
5086785 Gentile et al. Feb 1992 A
5115803 Sioutas May 1992 A
5134993 Van Der Linden et al. Aug 1992 A
5139016 Waser Aug 1992 A
5140740 Weigelt Aug 1992 A
5152456 Ross et al. Oct 1992 A
5157372 Langford Oct 1992 A
5164740 Irvi Nov 1992 A
5169029 Behar et al. Dec 1992 A
5170782 Kocinski Dec 1992 A
5186164 Raghuprasad Feb 1993 A
5186166 Riggs et al. Feb 1993 A
5198157 Bechet Mar 1993 A
5217492 Guire et al. Jun 1993 A
5258041 Guire et al. Nov 1993 A
5261601 Ross et al. Nov 1993 A
5263992 Guire Nov 1993 A
5297734 Toda Mar 1994 A
5299739 Takahashi et al. Apr 1994 A
5309135 Langford May 1994 A
5312281 Takashashi et al. May 1994 A
5320603 Vetter et al. Jun 1994 A
5347998 Hodson et al. Sep 1994 A
5414075 Swan et al. May 1995 A
5415161 Ryder May 1995 A
5419315 Rubsamen May 1995 A
5437267 Weinstein et al. Aug 1995 A
5452711 Gault Sep 1995 A
5477992 Jinks et al. Dec 1995 A
5487378 Robertson et al. Jan 1996 A
5512329 Guire Apr 1996 A
5512474 Clapper et al. Apr 1996 A
5515841 Robertson et al. May 1996 A
5515842 Ramseyer et al. May 1996 A
5518179 Humberstone et al. May 1996 A
5529055 Gueret Jun 1996 A
5533497 Ryder Jul 1996 A
5563056 Swan et al. Oct 1996 A
5579757 McMahon et al. Dec 1996 A
5586550 Ivri et al. Dec 1996 A
5609798 Liu et al. Mar 1997 A
5637460 Swan et al. Jun 1997 A
5654162 Guire et al. Aug 1997 A
5654460 Rong Aug 1997 A
5664557 Makiej, Jr. Sep 1997 A
5665068 Takamura Sep 1997 A
5692644 Gueret Dec 1997 A
5707818 Chudzik et al. Jan 1998 A
5714360 Swan et al. Feb 1998 A
5714551 Bezwada et al. Feb 1998 A
5718222 Lloyd et al. Feb 1998 A
5744515 Clapper Apr 1998 A
5755218 Johansson et al. May 1998 A
5758637 Ivri et al. Jun 1998 A
5893515 Hahn et al. Apr 1999 A
5938117 Ivri Aug 1999 A
5970974 Van Der Linden et al. Oct 1999 A
6012450 Rabsamen Jan 2000 A
6014970 Ivri et al. Jan 2000 A
6085740 Ivri et al. Jul 2000 A
6186141 Pike et al. Feb 2001 B1
6196219 Hess et al. Mar 2001 B1
Foreign Referenced Citations (33)
Number Date Country
477 885 Oct 1969 CH
555 681 Sep 1974 CH
0 049 636 Apr 1982 EP
0 103 161 Mar 1984 EP
0 134 847 Mar 1985 EP
0 178 925 Apr 1986 EP
0 542 723 May 1993 EP
0 476 991 Mar 1995 EP
2 692 569 Jun 1992 FR
973458 Oct 1964 GB
1454597 Nov 1976 GB
2 073 616 Oct 1981 GB
2 101 500 Jan 1983 GB
2 177 623 Jan 1987 GB
2 240 494 Aug 1991 GB
2 272 389 May 1994 GB
2 279 571 Jan 1995 GB
57-23852 Feb 1982 JP
57-105608 Jul 1982 JP
58-61857 Apr 1983 JP
58-139757 Aug 1983 JP
60-4714 Jan 1985 JP
61-8357 Jan 1986 JP
61-215059 Sep 1986 JP
2-135169 May 1990 JP
2-189161 Jul 1990 JP
WO 9207600 May 1992 WO
WO 9211050 Jul 1992 WO
WO 9301404 Jan 1993 WO
WO 9609229 Mar 1996 WO
WO 9631289 Oct 1996 WO
WO 9707896 Mar 1997 WO
WO 9963946 Dec 1999 WO
Non-Patent Literature Citations (17)
Entry
Berglund, R.N., et al. Generation of Monodisperse Aerosol Standards. Environ. Sci. Technology 7:2:147 (1973).
Allen, T. Particle Size Measurement. Chapman and Hall pp. 167-169 (1981).
Ueha, S., et al. Mechanism of Ultrasonic Atomization Using a Multi-Pinhole Plate. J. Acoust. Soc. Jpn. (E) 6,1:21 (1985).
Maehara, N., et al. Influence of the Vibrating System of a Multipinhole-plate Ultrasoic Nebulizer on Its Performance. Review of Scientific Instruments, 57 (11), Nov. 1986, pp. 2870-2876.
Maehara, N., et al. Optimum Design Procedure for Multi-Pinhole-plate Ultrasonic Atomizer. Japanese Journal of Applied Physics, 26:215 (1987).
Ashgriz, N., et al. Development of a Controlled Spray Generator. Rev. Sci. Instrum. 58(7):1291 (1987).
Hikayama, H., et al. Ultrasonic Atomizer with Pump Function. Tech. Rpt. IEICE Japan US88-74:25 (1988).
J. Acoustical Soc. Japan 44:2:116 (1988).
J. Acoustical Soc. Japan 44:6:425 (1988).
Siemens AG, 1989, “Ink-Jet Printing: The Present State of The Art,” by Wolfgang R. Wehl.
TSI Incorporated product catalog. Vibrating Orifice Aerosol Generator (1989).
Gaiser Tool Company catalog, pp. 26, 29-30 (19_).
Nogi, T., et al. Mixture Formation of Fuel Injection System in Gasoline Engine. Nippon Kikai Gakkai Zenkoku Taikai koenkai Koen Ronbunshu 69:660 (1991).
D.C. Cipolla et al., “Assesment of Aerosol Delivery Systems for Recombinant Human Deoxyribonuclease,” STP Pharma Sciences 4 (1) 50-62, 1994.
D.C. Cipolla et al., “Characterization of Aerosols of Human Recombinant Deoxyribonuclease I (rhDNase) Generated by Jet Nebulizers,” Pharmaceutical Research II 94) 491-498, 1994.
I. Gonda,. “Therapeutic Aerosols,” Pharmaceutics, The Sci. of Dosage Form Design, M.E. Aulton, 341-358, 1988.
Anthony J. Hickey, “Pharmaceutical Inhalation Aerosol Technology,” Drugs and the Pharmaceutical Sciences, (54) 172-173.